Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression
…, NF Neel, C Hu, P Gautam, M Chenard, B Long, M Aziz… - Cancer cell, 2016 - cell.com
Induction of compensatory mechanisms and ERK reactivation has limited the effectiveness
of Raf and MEK inhibitors in RAS-mutant cancers. We determined that direct pharmacologic …
of Raf and MEK inhibitors in RAS-mutant cancers. We determined that direct pharmacologic …
Cancer gene mutation frequencies for the US population
G Mendiratta, E Ke, M Aziz, D Liarakos, M Tong… - Nature …, 2021 - nature.com
Mutations play a fundamental role in the development of cancer, and many create
targetable vulnerabilities. There are both public health and basic science benefits from the …
targetable vulnerabilities. There are both public health and basic science benefits from the …
Hypoxia triggers hedgehog-mediated tumor–stromal interactions in pancreatic cancer
…, G Hostetter, R Posner, M Aziz… - Cancer …, 2013 - aacrjournals.org
Pancreatic cancer is characterized by a desmoplastic reaction that creates a dense
fibroinflammatory microenvironment, promoting hypoxia and limiting cancer drug delivery due to …
fibroinflammatory microenvironment, promoting hypoxia and limiting cancer drug delivery due to …
NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines
SP Tsofack, C Garand, C Sereduk, D Chow, M Aziz… - Molecular cancer, 2011 - Springer
Background YB-1 is a multifunctional protein that affects transcription, splicing, and translation.
Overexpression of YB-1 in breast cancers causes cisplatin resistance. Recent data have …
Overexpression of YB-1 in breast cancers causes cisplatin resistance. Recent data have …
Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4–ALK translocation as a therapeutic target
MJ Demeure, M Aziz, R Rosenberg, SD Gurley… - World Journal of …, 2014 - Springer
Background Recent advances in the treatment of cancer have focused on targeting genomic
aberrations with selective therapeutic agents. In radioiodine resistant aggressive papillary …
aberrations with selective therapeutic agents. In radioiodine resistant aggressive papillary …
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
…, T Knösel, P Rümmele, T Holley, M Kassner, M Aziz… - Genome medicine, 2014 - Springer
Background Pancreatic ductal adenocarcinoma (PDA) is a highly lethal cancer characterized
by complex aberrant genomes. A fundamental goal of current studies is to identify those …
by complex aberrant genomes. A fundamental goal of current studies is to identify those …
Specification, annotation, visualization and simulation of a large rule-based model for ERBB receptor signaling
Background Mathematical/computational models are needed to understand cell signaling
networks, which are complex. Signaling proteins contain multiple functional components and …
networks, which are complex. Signaling proteins contain multiple functional components and …
Use of mechanistic models to integrate and analyze multiple proteomic datasets
Proteins in cell signaling networks tend to interact promiscuously through low-affinity interactions.
Consequently, evaluating the physiological importance of mapped interactions can be …
Consequently, evaluating the physiological importance of mapped interactions can be …
Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia
…, MD Krieger, FH Gilles, FJ Couch, M Aziz… - Frontiers in …, 2015 - frontiersin.org
Medulloblastoma, the most common malignant brain tumor in children, occurs with increased
frequency in individuals with Fanconi anemia who have biallelic germline mutations in …
frequency in individuals with Fanconi anemia who have biallelic germline mutations in …
RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2
…, LA Bruins, CX Shi, P Jedlowski, M Aziz… - Blood, The Journal …, 2015 - ashpublications.org
To identify molecular targets that modify sensitivity to lenalidomide, we measured proliferation
in multiple myeloma (MM) cells transfected with 27 968 small interfering RNAs in the …
in multiple myeloma (MM) cells transfected with 27 968 small interfering RNAs in the …